Lithium
Lithium is a pharmaceutical drug with 90 clinical trials. Currently 8 active trials ongoing. Historical success rate of 85.5%.
Success Metrics
Based on 59 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
10
Mid Stage
50
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
79.7%
59 of 74 finished
20.3%
15 ended early
8
trials recruiting
90
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Preventing Relapse After Successful Electroconvulsive Therapy for Depression
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants
Clinical Trials (90)
Preventing Relapse After Successful Electroconvulsive Therapy for Depression
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Repurposing Lithium for Parkinson's Disease: a RCT
Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer
Effect of Lithium Therapy on Long COVID Symptoms
Lithium Long COVID Dose-finding Study
Lithium Versus Paroxetine in Major Depression
A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration
Treatment of Psychosis and Agitation in Alzheimer's Disease
Lithium for Suicidal Behavior in Mood Disorders
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder
Lithium Versus Anticonvulsants and the Risk of Physical Disorders
Effects of Lithium Therapy on Blood-based Therapeutic Targets in Parkinson's Disease.
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 90